Scientific Sessions 2024  /  Novel Mitral and Tricuspid Valve Therapies: Current Status and A Glimpse into the Future  /  Current Indications for TEER and Transcatheter Therapy in Mitral and Tricuspid Disease
Logo

American Heart Association

  107
  0

Final ID:

Current Indications for TEER and Transcatheter Therapy in Mitral and Tricuspid Disease

  • Asgar, Anita  ( INSTITUT DE CARDIOLOGIE DE MONTREAL , Montreal , Quebec , Canada )
  • Rodes-cabau, Josep  ( Quebec Heart and Lung Institute , Quebec , Quebec , Canada )
    • Author Disclosures:
    Anita Asgar: DO have relevant financial relationships ; Consultant:Abbott:Active (exists now) ; Consultant:Edwards :Active (exists now) ; Consultant:WL Gore:Active (exists now) ; Consultant:Medtronic:Active (exists now) | Josep Rodes-Cabau: DO have relevant financial relationships ; Research Funding (PI or named investigator):Edwards Lifesciences:Active (exists now) ; Consultant:Medtronic:Active (exists now) ; Research Funding (PI or named investigator):Medtronic:Active (exists now) ; Speaker:Edwards Lifesciences:Active (exists now)
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Novel Mitral and Tricuspid Valve Therapies: Current Status and A Glimpse into the Future

Sunday, 11/17/2024 , 03:30PM - 04:30PM

Hall

More abstracts on this topic:
Expansion of Indications for M-TEER: Evaluation of Transcatheter Repair in Lower Surgical Risk Cohorts (e.g. REPAIR-MR and PRIMARY)

Hahn Rebecca

Panel Discussion

Gillam Linda, Lindenfeld Joanne

More abstracts from these authors:
Is her heart too small for a TAVR?

Reed Grant, Puri Rishi, Rodes-cabau Josep, Krishnaswamy Amar

VIVA Trial: TAVR vs SAVR in Severe Aortic Stenosis and Small Aortic Annulus Randomized Clinical Trial

Pibarot Philippe, Rodés-cabau Josep, Forcillo Jessica, Coylewright Megan

You have to be authorized to contact abstract author. Please, Login
Not Available